Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
<h4>Background and objectives</h4> To compare the long-term clinical outcomes of dual antiplatelet therapy (DAPT) with clopidogrel and DAPT with ticagrelor or prasugrel in patients with acute myocardial infarction (AMI) who underwent coronary intervention. <h4>Methods</h4> Be...
Main Authors: | Yuri Kim, Myung Ho Jeong, Minjeong An, Kyunghoon Cho, Youngjoon Hong, Juhan Kim, Youngkeun Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949675/?tool=EBI |
Similar Items
-
Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention.
by: Yuri Kim, et al.
Published: (2023-01-01) -
Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
by: Jim McLenachan, et al.
Published: (2019-05-01) -
Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Published: (2019-07-01) -
Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
by: Vojko Kanic, et al.
Published: (2024-01-01) -
In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
by: Muhammad Naufal Hibatullah, et al.
Published: (2024-11-01)